Trading status Status de
  • Prices realtime
    • Indizes
      • Germany 40
      • MID Germany 50
      • TEC Germany 30
      • USA 30
      • EUROPE 50
      • TEC USA 100
    • Shares
    • ETFs & FUNDS
    • Bonds
    • Crypto
  • Screen markets
    • Stock screener
    • Certifcate Screener
    • ETF Screener
    • Fund Screener
    • Bond screener
  • Trading ideas
    • risk indices
      • risk indices
      • EU Intraday
      • EU Long Term
      • US Intraday
      • US Longterm
    • New on gettex
      • New listings stocks
      • New listings bonds
      • New intraday certificates
    • Blog
    • Newsletter
    • Watchlist
    • Support
  • Trading
    • Trading Calendar
    • Extended trading hours
    • Listing on demand
    • Announcements
    • Quality Reports
    • Delayed Data
    • Regulations
    • Become a Trade Participant
    • Cancellations
  • About Gettex
    • FAQs
    • Press
    • Partners
    • Committees
    • Career
    • Service & Contact
  • Why gettex

News overview

  • «
  • ‹
  • …
  • 9537
  • 9538
  • 9539
  • …
  • ›
  • »

2026-03-31

authID GAAP EPS of -$0.28, revenue of $0.4M

2026-03-31

Ameresco names co-presidents and COO

2026-03-31

SUNSTONE HOTEL INVESTORS SCHEDULES FIRST QUARTER 2026 EARNINGS RELEASE AND CONFERENCE CALL

2026-03-31

Nanobiotix GAAP EPS of -€0.50, revenue of €29.6M

2026-03-31

KULR Technology GAAP EPS of -$0.97, revenue of $2.86M

2026-03-31

Camden National Corporation Announces its First Quarter 2026 Dividend

2026-03-31

Galmed Pharmaceuticals Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2025

2026-03-31

Perimeter Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Financial Results Marked by Record Revenues and Improved Operating Performance

2026-03-31

Ynvisible Interactive Inc.: Ynvisible Announces Closing of Second Tranche of Non-Brokered Private Placement

2026-03-31

COPT Defense Provides Conference Call Details to Discuss Q1 2026 Results

2026-03-31

Ameresco Announces Executive Appointments to Drive Growth and Strengthen Operations

2026-03-31

FibroBiologics Announces Successful Manufacturing of CYWC628 Drug Product to Support Upcoming Diabetic Foot Ulcer Clinical Trial

  • «
  • ‹
  • …
  • 9537
  • 9538
  • 9539
  • …
  • ›
  • »

Preset online depot

Favorites: Zertifikate-Finder FAQs Newsletter
Tradingtime Mo-Fr: 7:30-23 h
Certificates 8:00-22 h
  • Imprint
  • Legal notice
  • Data protection
  • Contact
  • Cookies